Back to search

Article

Assessment of Molecular Markers of Anti-malarial Drug Resistance in Pfk13-propeller, Pfcrt and Pfmdr1 Genes in Plasmodium Falciparum Isolated From Patients Returning for Malaria Retreatment in Democratic Republic of Congo 

2020-10-12

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>The Democratic Republic of Congo (DRC) malaria treatment policy recommends two first-line artemisinin-based combination therapies (ACTs) for the treatment of uncomplicated malaria: Artesunate-amodiaquine (ASAQ) and Artemether-lumefantrine (AL). This study investigated resistance to the ACTs currently in use in DRC through molecular markers in <italic>pfk13,</itali...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0857f4e3-84df-5de1-b3b7-17823365bbe7
DOI
10.21203/rs.3.rs-87989/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Assessment of Molecular Markers of Anti-malarial Drug Resistance in Pfk13-propeller, Pfcrt and Pfmdr1 Genes in Plasmodium Falciparum Isolated From Patients Returning for Malaria Retreatment in Democratic Republic of Congo&nbsp;DOI 10.21203/rs.3.rs-87989/v1
Select a neighboring publication to make it the new centre.